Cargando…
THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
Disclosure: S. Venugopal: None. S. Patel: None. Z. Wu: None. F. Galbiati: None. J. Oh: None. P. Manroa: None. E. Morariu: None. M. Stefanovic-Racic: None. Introduction: Fournier’s gangrene (FG) is a rare, necrotizing fasciitis of the external genitalia with high mortality up to 30% that is more prev...
Autores principales: | Venugopal, Sharini, Patel, Suraj, Wu, Zhengbo, Galbiati, Francesca, Oh, Jessica, Manroa, Pooja, Morariu, Elena, Stefanovic-Racic, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553673/ http://dx.doi.org/10.1210/jendso/bvad114.718 |
Ejemplares similares
-
THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023) -
PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022) -
LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022) -
SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020) -
Fournier’s Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
por: Chowdhury, Tutul, et al.
Publicado: (2022)